Market Watch
Portfolio Manager

Last Price Change Volume
KLSE Market Watch
Open: Day Range: Prev Close:
Market Date: 14 Jun 2018

Trade Detail

Trade Value (RM)
4 Weeks Range
4 Weeks Change (%)
Avg Volume (4 Weeks)
1 Year Range
1 Year Change (%)
Avg Volume (1 Year)

Market Capital (RM)
Number of Share
EPS (cent)
P/E Ratio
ROE (%)
Dividend (cent)
Dividend Yield (%)
Dividend Policy (%)
Par Value (RM)

* Calculated based on the net profit of the trailing twelve months and latest number of shares issued.

No. Financial
PBT (RM,000)Net Profit
EPS (Cent)Dividend
16 May 201831 Dec 2018131 Mar 2018617,92328,70717,5866.775.002.020 Malaysia Stock - KLSE Quarter Report History
27 Feb 201831 Dec 2017431 Dec 2017613,19619,86621,7008.366.002.030 Malaysia Stock - KLSE Quarter Report History
15 Nov 201731 Dec 2017330 Sep 2017574,50315,2713,5801.385.002.050 Malaysia Stock - KLSE Quarter Report History
16 Aug 201731 Dec 2017230 Jun 2017517,96710,1509,5203.674.002.090 Malaysia Stock - KLSE Quarter Report History
16 May 201731 Dec 2017131 Mar 2017618,29427,77718,9237.304.002.100 Malaysia Stock - KLSE Quarter Report History
21 Feb 201731 Dec 2016431 Dec 2016582,8164,069-836-0.323.002.050 Malaysia Stock - KLSE Quarter Report History
21 Nov 201631 Dec 2016330 Sep 2016515,21519,92313,0615.044.002.050 Malaysia Stock - KLSE Quarter Report History
19 Aug 201631 Dec 2016230 Jun 2016531,79621,48714,9955.795.002.024 Malaysia Stock - KLSE Quarter Report History
13 May 201631 Dec 2016131 Mar 2016559,19526,53818,3797.104.001.993 Malaysia Stock - KLSE Quarter Report History
15 Feb 201631 Dec 2015431 Dec 2015680,15023,71716,0626.207.002.045 Malaysia Stock - KLSE Quarter Report History
26 Nov 201531 Dec 2015330 Sep 2015524,41325,33719,9717.719.002.063 Malaysia Stock - KLSE Quarter Report History
17 Aug 201531 Dec 2015230 Jun 2015512,84525,05616,2176.267.002.040 Malaysia Stock - KLSE Quarter Report History

Entitlement TypeDividend
16 May 201831 Dec 201830 May 201801 Jun 201820 Jun 2018First Interim Dividend5.00000.00 Malaysia Stock -  Dividend
27 Feb 201831 Dec 201713 Mar 201815 Mar 201828 Mar 2018Interim Dividend6.00000.00 Malaysia Stock -  Dividend
15 Nov 201731 Dec 201729 Nov 201704 Dec 201715 Dec 2017Interim Dividend5.00000.00 Malaysia Stock -  Dividend
01 Sep 201731 Dec 201729 Aug 201705 Sep 201718 Sep 2017Interim Dividend4.00000.00 Malaysia Stock -  Dividend
16 May 201731 Dec 201729 May 201731 May 201707 Jun 2017Interim Dividend4.00000.00 Malaysia Stock -  Dividend
21 Feb 201731 Dec 201607 Mar 201709 Mar 201717 Mar 2017Interim Dividend3.00000.00 Malaysia Stock -  Dividend
21 Nov 201631 Dec 201605 Dec 201607 Dec 201615 Dec 2016Interim Dividend4.00000.00 Malaysia Stock -  Dividend
19 Aug 201631 Dec 201602 Sep 201606 Sep 201620 Sep 2016Interim Dividend5.00000.00 Malaysia Stock -  Dividend
13 May 201631 Dec 201601 Jun 201603 Jun 201628 Jun 2016Interim Dividend4.00000.00 Malaysia Stock -  Dividend
15 Feb 201631 Dec 201501 Mar 201603 Mar 201625 Mar 2016Interim Dividend7.00000.00 Malaysia Stock -  Dividend
26 Nov 201531 Dec 201509 Dec 201511 Dec 201521 Dec 2015Interim Dividend9.00000.00 Malaysia Stock -  Dividend
17 Aug 201531 Dec 201501 Sep 201503 Sep 201515 Sep 2015Interim Dividend7.00000.00 Malaysia Stock -  Dividend

TypeRatioRight Issue
20 May 201331 May 201304 Jun 201304 Jun 2013Bonus Issue1 : 100.000 Malaysia Stock -  Bonus/Rights Issue
20 May 201331 May 201304 Jun 201304 Jun 2013Others2 : 10.000 Malaysia Stock -  Bonus/Rights Issue
31 Jan 201215 Feb 201217 Feb 201217 Feb 2012Bonus Issue1 : 100.000 Malaysia Stock -  Bonus/Rights Issue

Member Star
Posts: 107
Joined: Dec 2011
Female, MYS
16 Mar 2012, 08:22 PMPost #1
Pharmaniaga to expand in MidEast, SE Asia
Published: 2012/03/16

Malaysia’s largest local pharmaceutical firm, Pharmaniaga Bhd plans to expand its market in the Middle East and Southeast Asia, particularly, Saudi Arabia, Indonesia, Myanmar and Vietnam.

Chairman Tan Sri Lodin Wok Kamaruddin said the company is looking for growth opportunities in these countries including through mergers and acquisitions.

“We are exploring opportunities in Saudi Arabia as it is a growing market. There is also potential for us to expand in neighbouring countries such as Indonesia, Vietnam and Myanmar. We already have a presence in a few Southeast Asian countries through joint ventures or collaborations but we want to do much more, ” Lodin told Bernama in an interview.

He said there is room for Pharmaniaga to grow but the group's plan is to focus on improving delivery, which requires the company to expand the list of drugs that it is currently supplying to customers.

“We believe we can do more. We have to improve on the delivery of the supply to meet the requirements of the markets,” Lodin said.

According to Lodin, one of the ways to expand its product portfolio is by growing its halal drugs and herbal medicines.
He also said that Pharmaniaga has been performing very well since it was taken over by Boustead Holdings Bhd and with the new management team in place.

He noted that Pharmaniaga’s acquisition of a 51 per cent stake in Idaman Pharma Manufacturing would see improvement in costs, resulting from the streamlining and optimising of manufacturing facilities and production capacities.

Pharmaniaga has also secured a 10-year concession agreement with the Health Ministry to supply drugs and medical items to 3,517 government hospitals and clinics nationwide beginning December 2009. It was reported that the contract was worth RM900 million a year.

For the financial year ended Dec 31 2011, Pharmaniaga’s net profit surged 65.1 per cent to RM52.16 million from RM30.38 million a year ago.

Lodin also said that Pharmaniaga is in the process of meeting the 25 percent public shareholding spread as required by Bursa Malaysia.

“We are still a little bit short, around of 7-8 per cent to meet the required 25 percent. We hope to meet the 25 per cent before April or May,” Lodin said.

He noted that Boustead, recently, had improved the public shareholding spread in Pharmaniaga from two per cent at the completion of its general offer to 17 per cent currently.

He said Boustead, which acquired Pharmaniaga in 2010, might further pare down its shareholding in the pharmaceutical company to meet the 25 per cent public spread.

As at February 20 this year, Boustead holds a 72.36 per cent stake in Pharmaniaga. -- Bernama

Member Star
Posts: 8
Joined: Mar 2016
Female, MYS
01 Apr 2016, 07:55 AMPost #2
PHARMA AGM 2016 story - http://mytownpharmacy.blogspot.my/2016/03/pharma-agm-2016.html

yeah doh drool lol mad notworthy question rant rolleyes sad shutup shy smile star sweat thumbup wub cry